Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

Peginterferon α-2b plus an anti-PD-1

Percutaneous transhepatic biliary stenting with conventional linear ^125^I seeds strand

Phase 1 Wonderlab Product

Placebo 1 to Probiotic A

RB001

REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]

RT-PCR Test

Radiotherapy combined with TKI and Anti-PD-1 Antibody

Recombinant COVID-19 Vaccine (Sf9 Cell)

Reduction CTVp1

Romiplostim N01

Ropivacaine Hydrochloride 10 MG/ML [Naropin]

SA58 Nasal Spray

SPECT/CT imaging with 99mTc-P137 nuclide probe

Secukinumab 300 MG; Tofacitinib 11mg

Senl_B19 autologous CAR-T (S1904) treatment

Sildenafil 100 MG

Sperm test

Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval

TIV 2010/2011 influenza vaccine

Technochrom C1-INH Kit

Tranexamic Acid 100Mg/Ml Inj Vil 10Ml

UC-MSCs

Ulinastatin and Thymosin α1

Frequently asked questions